Abstract

Surgical ventricular remodeling (SVR) is an accepted therapy for end-stage congestive heart failure. Surgical options are limited for patients (pts) with severe left ventricular dysfunction. We assessed outcomes of SVR in pts with preoperative ejection fraction (EF) ≤20%.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call